286 related articles for article (PubMed ID: 33439450)
1. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.
Akan O; Baysal-Kirac L
Acta Neurol Belg; 2021 Oct; 121(5):1131-1140. PubMed ID: 33439450
[TBL] [Abstract][Full Text] [Related]
2. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
3. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Kupersmith MJ
J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
[TBL] [Abstract][Full Text] [Related]
4. Prognostic predictors of remission in ocular myasthenia gravis.
Çelebisoy N; Orujov A; Balayeva F; Özdemir HN; Ak AK; Gökçay F
Acta Neurol Belg; 2023 Oct; 123(5):1927-1932. PubMed ID: 36474006
[TBL] [Abstract][Full Text] [Related]
5. Low probability of myasthenia Gravis in patients presenting to neuro-ophthalmology clinic for evaluation of isolated ptosis.
Donaldson L; Issa M; Dezard V; Margolin E
Eur J Ophthalmol; 2023 Jan; 33(1):524-529. PubMed ID: 35686323
[TBL] [Abstract][Full Text] [Related]
6. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
7. Inferior oblique muscle paresis as a sign of myasthenia gravis.
Almog Y; Ben-David M; Nemet AY
J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
[TBL] [Abstract][Full Text] [Related]
8. Childhood myasthenia gravis: clinical features and outcomes.
Sri-udomkajorn S; Panichai P; Liumsuwan S
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis.
Chirapapaisan N; Tanormrod S; Chuenkongkaew W
Asian Pac J Allergy Immunol; 2007 Mar; 25(1):13-6. PubMed ID: 17891917
[TBL] [Abstract][Full Text] [Related]
10. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
11. Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis.
Keene KR; Kan HE; van der Meeren S; Verbist BM; Tannemaat MR; Beenakker JM; Verschuuren JJGM
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2820-2834. PubMed ID: 36172973
[TBL] [Abstract][Full Text] [Related]
12. An unusual presentation of myasthenia gravis.
Chijoke A; Ogunmodele JA
West Afr J Med; 2009; 28(6):391-3. PubMed ID: 20486100
[TBL] [Abstract][Full Text] [Related]
13. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
Valko Y; Wirth MA; Fierz FC; Schesny MK; Rosengren S; Schmückle-Meier T; Bockisch CJ; Straumann D; Schreiner B; Weber KP
Neurology; 2024 May; 102(10):e209395. PubMed ID: 38669629
[TBL] [Abstract][Full Text] [Related]
15. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
[TBL] [Abstract][Full Text] [Related]
16. Ice pack test: is it obsolete?
Rajasekharan C; Anishkumar V; Suresh MK
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689834
[TBL] [Abstract][Full Text] [Related]
17. Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature.
de Meel RHP; Raadsheer WF; van Zwet EW; Tannemaat MR; Verschuuren JJGM
J Neuromuscul Dis; 2019; 6(3):369-376. PubMed ID: 31424417
[TBL] [Abstract][Full Text] [Related]
18. Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital.
Leeamornsiri S; Chirapapaisan N; Chuenkongkaew W
J Med Assoc Thai; 2011 Sep; 94(9):1117-21. PubMed ID: 21970202
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmologic clinical features of ocular myasthenia gravis.
Kim DH; Roh HC; Oh SY
Medicine (Baltimore); 2023 Jan; 102(2):e31972. PubMed ID: 36637960
[TBL] [Abstract][Full Text] [Related]
20. Ocular aspects of myasthenia gravis.
Barton JJ; Fouladvand M
Semin Neurol; 2000; 20(1):7-20. PubMed ID: 10874773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
